Chuling Hu

856 total citations
24 papers, 667 citations indexed

About

Chuling Hu is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Chuling Hu has authored 24 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Biomaterials. Recurrent topics in Chuling Hu's work include RNA Interference and Gene Delivery (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Chuling Hu is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Radiomics and Machine Learning in Medical Imaging (5 papers). Chuling Hu collaborates with scholars based in China and Hong Kong. Chuling Hu's co-authors include Fenfen Gu, Shen Gao, Yuan Gao, Qingming Xia, Chunai Gong, Lijuan Zhang, Chong Yao, Zhuo Wang, Zongguang Tai and Huiling Guo and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Chuling Hu

22 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuling Hu China 12 411 197 186 177 70 24 667
Fenfen Gu China 13 399 1.0× 222 1.1× 178 1.0× 206 1.2× 55 0.8× 19 646
Xinchun Xu China 11 419 1.0× 131 0.7× 78 0.4× 203 1.1× 56 0.8× 18 663
Qinglian Wen China 18 284 0.7× 195 1.0× 161 0.9× 172 1.0× 164 2.3× 48 756
Noriyuki Maeda Japan 16 442 1.1× 238 1.2× 93 0.5× 289 1.6× 55 0.8× 20 674
Chong Du China 18 569 1.4× 116 0.6× 323 1.7× 104 0.6× 194 2.8× 41 898
Meghna Mehta United States 15 732 1.8× 260 1.3× 304 1.6× 236 1.3× 129 1.8× 20 1.1k
Chunwen Pu China 8 599 1.5× 163 0.8× 141 0.8× 89 0.5× 225 3.2× 9 866
Noemi Arrighetti Italy 14 548 1.3× 187 0.9× 200 1.1× 128 0.7× 124 1.8× 26 790
Dan Peer Israel 12 540 1.3× 151 0.8× 163 0.9× 97 0.5× 66 0.9× 24 776
Kaylin M. McMahon United States 17 581 1.4× 195 1.0× 313 1.7× 194 1.1× 86 1.2× 26 976

Countries citing papers authored by Chuling Hu

Since Specialization
Citations

This map shows the geographic impact of Chuling Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuling Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuling Hu more than expected).

Fields of papers citing papers by Chuling Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuling Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuling Hu. The network helps show where Chuling Hu may publish in the future.

Co-authorship network of co-authors of Chuling Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuling Hu. A scholar is included among the top collaborators of Chuling Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuling Hu. Chuling Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Junwei, Yibin Zhao, Yuezhe Li, et al.. (2025). CRCFound: A Colorectal Cancer CT Image Foundation Model Based on Self‐Supervised Learning. Advanced Science. 12(41). e07339–e07339.
2.
Gao, Feng, Chuling Hu, Ruikun He, et al.. (2025). Interpretable Multimodal Fusion Model for Bridged Histology and Genomics Survival Prediction in Pan‐Cancer. Advanced Science. 12(17). e2407060–e2407060. 4 indexed citations
3.
Yang, Qiuxia, Yuezhe Li, Chuling Hu, et al.. (2025). Personalized risk stratification in colorectal cancer via PIANOS system. Nature Communications. 16(1). 6561–6561.
4.
Hu, Chuling, Yan Liu, Wei Cao, et al.. (2024). Efficacy and Mechanism of a Biomimetic Nanosystem Carrying Doxorubicin and an IDO Inhibitor for Treatment of Advanced Triple-Negative Breast Cancer. International Journal of Nanomedicine. Volume 19. 507–526. 7 indexed citations
5.
Hu, Chuling, Zhaoliang Yu, Xinxin Huang, et al.. (2024). KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF‑β mediated epithelial‑mesenchymal transition. Molecular Medicine Reports. 31(1). 2 indexed citations
6.
Li, Yuezhe, Guoqin Chen, Chuling Hu, et al.. (2023). Senescence‐based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies. SHILAP Revista de lepidopterología. 4(4). e333–e333. 9 indexed citations
7.
Wang, Wei, Min‐Er Zhong, Dejun Fan, et al.. (2023). An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer. Cancer Medicine. 12(7). 8924–8936. 2 indexed citations
8.
Nijiati, Mayidili, Jie Ma, Chuling Hu, et al.. (2022). Artificial Intelligence Assisting the Early Detection of Active Pulmonary Tuberculosis From Chest X-Rays: A Population-Based Study. Frontiers in Molecular Biosciences. 9. 874475–874475. 26 indexed citations
9.
Wang, Wei, Min‐Er Zhong, Dejun Fan, et al.. (2022). DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients. Frontiers in Genetics. 13. 872238–872238. 7 indexed citations
10.
Nijiati, Mayidili, Chuling Hu, Li Li, et al.. (2022). Deep learning based CT images automatic analysis model for active/non-active pulmonary tuberculosis differential diagnosis. Frontiers in Molecular Biosciences. 9. 1086047–1086047. 8 indexed citations
11.
Li, Yuezhe, Min‐Er Zhong, Ze-Ping Huang, et al.. (2022). Multi-Size Deep Learning Based Preoperative Computed Tomography Signature for Prognosis Prediction of Colorectal Cancer. Frontiers in Genetics. 13. 880093–880093. 7 indexed citations
12.
Gu, Fenfen, Chuling Hu, Wei Cao, et al.. (2022). Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer. International Journal of Nanomedicine. Volume 17. 4401–4417. 14 indexed citations
13.
Hu, Chuling, Fenfen Gu, Chunai Gong, et al.. (2021). Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment. Journal of Biomaterials Applications. 36(7). 1317–1331. 13 indexed citations
14.
Gu, Fenfen, et al.. (2018). Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer. Journal of Nanoparticle Research. 20(11). 303–303. 39 indexed citations
15.
Li, Yan, Yuan Gao, Chunai Gong, et al.. (2018). A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer. Nanomedicine Nanotechnology Biology and Medicine. 14(7). 1973–1985. 188 indexed citations
16.
Jiang, Wenjun, Yuan Gao, Zhuo Wang, et al.. (2018). Codelivery of miR-4638–5p and Docetaxel Based on Redox-Sensitive Polypeptide Micelles as an Improved Strategy for the Treatment of Castration-Resistant Prostate Cancer. Molecular Pharmaceutics. 16(1). 437–447. 14 indexed citations
17.
Gong, Chunai, Chuling Hu, Fenfen Gu, et al.. (2017). Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. Journal of Controlled Release. 266. 272–286. 86 indexed citations
18.
Chen, Zhongjian, Zongguang Tai, Fenfen Gu, et al.. (2016). Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy. European Journal of Pharmaceutics and Biopharmaceutics. 107. 130–141. 67 indexed citations
19.
Yao, Chong, Jiyong Liu, Xin Wu, et al.. (2016). Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy. Journal of Controlled Release. 232. 203–214. 81 indexed citations
20.
Gu, Fenfen, Chuling Hu, Chong Yao, et al.. (2016). Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer. Scientific Reports. 6(1). 36281–36281. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026